Cargando…
Mutation analysis of RAD51D in non-BRCA1/2 ovarian and breast cancer families
BACKGROUND: Recent data show that mutations in RAD51D have an aetiological role in ovarian carcinoma, yet mutations do not appear to be associated with an increased risk for breast cancer. We studied ovarian and breast cancer families having at least one woman affected by ovarian carcinoma, to asses...
Autores principales: | Osher, D J, De Leeneer, K, Michils, G, Hamel, N, Tomiak, E, Poppe, B, Leunen, K, Legius, E, Shuen, A, Smith, E, Arseneau, J, Tonin, P, Matthijs, G, Claes, K, Tischkowitz, M D, Foulkes, W D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326673/ https://www.ncbi.nlm.nih.gov/pubmed/22415235 http://dx.doi.org/10.1038/bjc.2012.87 |
Ejemplares similares
-
RAD51C germline mutations in breast and ovarian cancer patients
por: Akbari, Mohammad R, et al.
Publicado: (2010) -
Contributions of the RAD51 N-terminal domain to BRCA2-RAD51 interaction
por: Subramanyam, Shyamal, et al.
Publicado: (2013) -
Clinical Characteristics of Ovarian Cancer Classified by BRCA1, BRCA2, and RAD51C Status
por: Cunningham, J. M., et al.
Publicado: (2014) -
Mutation analysis of PALB2 in BRCA1 and BRCA2-negative breast and/or ovarian cancer families from Eastern Ontario, Canada
por: Hartley, Taila, et al.
Publicado: (2014) -
Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations
por: Gonzalez, R, et al.
Publicado: (1999)